Northwest Biotherapeutics Inc (NWBO) stock
NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.16−0.00 (-0.88%)
Close on Oct 19, 2026Market cap $254.79MP/E –Yield –
Northwest Biotherapeutics cash
Cash and short-term investments held at the end of each period.
Northwest Biotherapeutics's cash was $595.00K at Jun 30, 2026. For fiscal 2025 it was $3.04M, up 39.8% from the year before. Over ten years it grew -18.3% a year on average. The highest annual figure on record is $23.05M in fiscal 2015.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.04M | +39.8% |
| FY2024 | Dec 31, 2024 | $2.18M | +2.3% |
| FY2023 | Dec 31, 2023 | $2.13M | -69.5% |
| FY2022 | Dec 31, 2022 | $6.97M | -54.1% |
| FY2021 | Dec 31, 2021 | $15.17M | +51.9% |
| FY2020 | Dec 31, 2020 | $9.98M | +2583.6% |
| FY2019 | Dec 31, 2019 | $372.00K | -98.3% |
| FY2018 | Dec 31, 2018 | $22.22M | +18894.9% |
| FY2017 | Dec 31, 2017 | $117.00K | -98.3% |
| FY2016 | Dec 31, 2016 | $6.87M | -70.2% |
| FY2015 | Dec 31, 2015 | $23.05M | +43.9% |
| FY2014 | Dec 31, 2014 | $16.02M | -13.4% |
| FY2013 | Dec 31, 2013 | $18.50M | +151.8% |
| FY2012 | Dec 31, 2012 | $7.35M | +30508.3% |
| FY2011 | Dec 31, 2011 | $24.00K | -84.3% |
| FY2010 | Dec 31, 2010 | $153.00K | +135.4% |
| FY2009 | Dec 31, 2009 | $65.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $595.00K | -86.2% |
| Q1 FY2026 | Mar 31, 2026 | $1.79M | -35.7% |
| Q4 FY2025 | Dec 31, 2025 | $3.04M | +39.8% |
| Q3 FY2025 | Sep 30, 2025 | $4.56M | +55.2% |
| Q2 FY2025 | Jun 30, 2025 | $4.32M | +49.8% |
| Q1 FY2025 | Mar 31, 2025 | $2.78M | +12.1% |
| Q4 FY2024 | Dec 31, 2024 | $2.18M | +2.3% |
| Q3 FY2024 | Sep 30, 2024 | $2.94M | -51.8% |
| Q2 FY2024 | Jun 30, 2024 | $2.88M | +102.3% |
| Q1 FY2024 | Mar 31, 2024 | $2.48M | -60.0% |
| Q4 FY2023 | Dec 31, 2023 | $2.13M | -69.5% |
| Q3 FY2023 | Sep 30, 2023 | $6.10M | -35.3% |
| Q2 FY2023 | Jun 30, 2023 | $1.42M | -70.5% |
| Q1 FY2023 | Mar 31, 2023 | $6.19M | -11.1% |
| Q4 FY2022 | Dec 31, 2022 | $6.97M | -54.1% |
| Q3 FY2022 | Sep 30, 2022 | $9.43M | +145.7% |
| Q2 FY2022 | Jun 30, 2022 | $4.83M | +28.6% |
| Q1 FY2022 | Mar 31, 2022 | $6.96M | -30.3% |
| Q4 FY2021 | Dec 31, 2021 | $15.17M | +64.0% |
| Q3 FY2021 | Sep 30, 2021 | $3.84M | -35.6% |
| Q2 FY2021 | Jun 30, 2021 | $3.76M | +391.9% |
| Q4 FY2020 | Dec 31, 2020 | $9.98M | +2583.6% |
| Q3 FY2020 | Sep 30, 2020 | $9.25M | +369.5% |
| Q2 FY2020 | Jun 30, 2020 | $5.96M | -10.8% |
| Q1 FY2020 | Mar 31, 2020 | $764.00K | -61.2% |
| Q4 FY2019 | Dec 31, 2019 | $372.00K | -98.3% |
| Q3 FY2019 | Sep 30, 2019 | $1.97M | +694.4% |
| Q2 FY2019 | Jun 30, 2019 | $6.68M | +318.0% |
| Q1 FY2019 | Mar 31, 2019 | $1.97M | +894.9% |
| Q4 FY2018 | Dec 31, 2018 | $22.22M | +18894.9% |
| Q3 FY2018 | Sep 30, 2018 | $248.00K | -76.4% |
| Q2 FY2018 | Jun 30, 2018 | $1.60M | -76.8% |
| Q1 FY2018 | Mar 31, 2018 | $198.00K | -86.7% |
| Q4 FY2017 | Dec 31, 2017 | $117.00K | -96.2% |
| Q3 FY2017 | Sep 30, 2017 | $1.05M | -91.7% |
| Q4 FY2016 | Dec 31, 2016 | $6.87M | -70.2% |
| Q3 FY2016 | Sep 30, 2016 | $1.49M | – |
| Q2 FY2016 | Jun 30, 2016 | $3.10M | – |
| Q1 FY2016 | Mar 31, 2016 | $12.65M | – |
| Q4 FY2015 | Dec 31, 2015 | $23.05M | – |
See a number that looks wrong?